The expression of ZEB1-AS1 has been reported and was identified as an oncogene in several cancer types, such as gastric cancer (Xu et al., 2017), prostate cancer (Su et al., 2017), colorectal cancer (Xiong et al., 2018), and glioma (Lv et al., 2016). Here, ZEB1 is linked to glioma.